freshnews.com
 
   Tech Calendar of Events California Tech News Updated Daily! FREE Daily Newsletter- 3,000 + Local Tech Links

FreshNews.com    FREE eNewsletter     "Local Tech Buzzzzz"

FreshPatents.com
Track New Patents
& Technologies


Port Townsend Wooden Boat Festival
Over 200 photos! WoodenBoatFestival.net

Access the Freshnews.com Media Kit
Keep FreshNews FREE

Explore the World.
Spain pictures
,
France pictures
and
Italy pictures

Promote Your Company To Technology Managers
"Click here for Results"

Submit Your Local Tech Events - It's FREE to Submit
Click Here

Access the Freshnews.com Media Kit
Keep FreshNews FREE

Submit Your Local Tech Events - It's FREE to Submit
Click Here

Access the Freshnews.com Media Kit
Keep FreshNews FREE

Promote Your Company To Technology Managers
"Click here for Results"

<< Return to company listing
< COMPANY NEWS >

Invitrogen

Website: http://www.invitrogen.com
Stock symbol: IVGN

Invitrogen News (2003-2004)
Thursday, December 4, 2008
SAN DIEGO--- NovaRx Appoints Industry Veteran as President and COO Posted 9:47 AM PST
 
Applied Biosystems SOLiD System Named Life Science Innovation of the Year Posted 7:41 AM PST
 
Tuesday, December 2, 2008
Applied Biosystems – Part of Life Technologies – Helps China Respond to Melamine Contamination in Dairy Products Posted 8:51 AM PST
 
Monday, December 1, 2008
SAN DIEGO--- San Diego Science Festival Receives More than $500K in Generous Contributions from Area's Leading Biotechnology and Technology Firms; Over 500 Events are Scheduled for this Free Event Posted 9:15 AM PST
 
Monday, November 24, 2008
Life Technologies to Present at J.P. Morgan Small/Mid Cap Conference Posted 4:22 PM PST
 
Friday, November 21, 2008
CARLSBAD--- Invitrogen and Applied Biosystems Complete Merger Posted 3:17 PM PST
 
Thursday, November 20, 2008
Invitrogen and Applied Biosystems Announce Preliminary Results of Election Regarding Merger Consideration Posted 9:00 AM PST
 
Wednesday, November 19, 2008
Invitrogen Launches In Vivo RNAi Delivery Reagent; Products to Simplify and Enable Research on All Sequencing Platforms Posted 3:57 PM PST
 
Tuesday, November 11, 2008
Invitrogen, BayBio Sign Partnership Agreement Posted 6:24 AM PST
 
Monday, November 10, 2008
High Resolution Nucleic Acid Separation Technologies Capture Significant Share in Large Nucleic Acid Electrophoresis Market Posted 6:41 AM PST
 
Thursday, November 6, 2008
Invitrogen Launches Microarray to Study Non-Coding RNA Posted 5:57 AM PST
 
Thursday, October 30, 2008
Dataskill Expands International Presence, Opens Mexico Office Posted 1:28 PM PST
 
Wednesday, October 29, 2008
Invitrogen Shareholders Approve Merger with Applied Biosystems Posted 5:08 AM PST
 
Friday, October 10, 2008
Invitrogen Launches Countess™ Posted 5:07 AM PST
 
Thursday, October 9, 2008
Invitrogen Announces Completion of Detailed Integration Plans Relating to Applied Biosystems Combination Posted 10:38 AM PST
 
Wednesday, October 8, 2008
Invitrogen Redesigns GIBCO® Bottle to Improve Form and Function Posted 5:10 AM PST
 
Monday, October 6, 2008
Applied Biosystems, Amaxa, and Invitrogen Lead Attractive Gene Silencing Market - Revealed in New Life Science Dashboard™ Market Research Report Posted 11:54 AM PST
 
Monday, September 29, 2008
SAN DIEGO--- CONNECT Announces 2008 Finalists For Most Innovative New Product Awards Nominees Selected for Innovation in San Diego Technology and Life Sciences Sectors Posted 8:24 AM PST
 
Friday, September 26, 2008
CARLSBAD--- Invitrogen Completes Syndication of Financing for Applied Biosystems Acquisition Posted 7:50 AM PST
 
Monday, September 22, 2008
Invitrogen Launches Stem Cell Culture Services; Service to Support Customers' Needs in Clinical Cell Therapy Arena Posted 4:20 PM PST
 
Wednesday, September 17, 2008
Invitrogen to Present at UBS Global Life Sciences Conference Posted 3:55 PM PST
 
CARLSBAD--- Invitrogen and Applied Biosystems Announce Divisional Structure and Executive Leadership Team Posted 4:02 PM PST
 
Monday, September 15, 2008
Invitrogen, Biocare to Market FDA Approved Breast Cancer Test Posted 2:44 PM PST
 
Thursday, September 11, 2008
Invitrogen and Applied Biosystems Announce Filing and Effectiveness of Definitive Joint Proxy Statement/Prospectus Posted 7:53 AM PST
 
Wednesday, September 10, 2008
Invitrogen Named Biotechnology Sector Leader by Dow Jones Sustainability World Index; Company’s sustainability record among top 10 percent of large companies worldwide Posted 3:10 PM PST
 
Friday, September 5, 2008
CARLSBAD--- Invitrogen Names Joe Beery Senior Vice President, Chief Information Officer Posted 7:26 AM PST
 
Thursday, September 4, 2008
Invitrogen Launches Patent Licensing Program for Enabling Amplification Technology Posted 7:29 AM PST
 
Monday, August 25, 2008
Invitrogen Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger with Applied Biosystems Posted 6:15 AM PST
 
Tuesday, August 19, 2008
Invitrogen Launches Legionella Test to Streamline Surveillance Posted 7:29 AM PST
 
Wednesday, August 6, 2008
Brendan Technologies Secures Pre-Release Purchase of STATLIA Quantum with Top Ten Pharmaceutical Company Posted 6:41 AM PST
 
Monday, August 4, 2008
Invitrogen, Lentigen to Provide Lentivirus Products and Services for Gene Over-Expression Posted 5:54 AM PST
 
Wednesday, July 30, 2008
Invitrogen Licenses Stem Cell Line from Buck Institute Posted 4:52 PM PST
 
Friday, July 11, 2008
Invitrogen to Integrate Brendan Technologies’ Advanced Analytical Software into Protein Analysis Solutions Posted 7:44 AM PST
 
Tuesday, July 8, 2008
FDA Grants Invitrogen Premarket Approval of Breast Cancer Test Posted 7:42 AM PST
 
Monday, June 30, 2008
Invitrogen and the Génome Québec and Montreal Heart Institute Pharmacogenomics Centre Announce Collaboration to Advance Pharmacogenomics Research Posted 2:52 PM PST
 
Tuesday, June 24, 2008
Invitrogen Advances Drug Discovery Safety Testing Posted 2:39 PM PST
 
Friday, June 20, 2008
CARLSBAD--- Invitrogen Announces Leader and Formation of Integration Team Posted 5:37 AM PST
 
Thursday, June 12, 2008
CARLSBAD--- Invitrogen and Applied Biosystems to Combine in Transaction Vauled at $6.7 Billion Posted 7:25 AM PST
 
Wednesday, June 4, 2008
Invitrogen Wins Six Life Science Industry Awards Posted 1:56 PM PST
 
Tuesday, June 3, 2008
Invitrogen Receives FDA Clearance for Diagnostic System to Help Determine Transplant Compatibility Posted 5:37 PM PST
 
Thursday, May 22, 2008
Invitrogen Launches First Ever Serum Free Media for Mesenchymal Stem Cells Posted 6:46 AM PST
 
Monday, May 19, 2008
Invitrogen Advances Next Generation Sequencing Workflows Posted 3:55 PM PST
 
Friday, May 16, 2008
Invitrogen Launches Cell Therapy Business Unit Posted 6:02 AM PST
 
Tuesday, May 13, 2008
Invitrogen Launches New Animal Origin Free Substrate for Stem Cells Posted 8:52 AM PST
 
Thursday, May 8, 2008
Nvitrogen and WARF Sign License Agreement for Human Embryonic Stem Cells Posted 8:05 AM PST
 
Wednesday, May 7, 2008
Invitrogen Scientists Link microRNA Sequences to Cancer Using RNA Samples from BioServe Posted 6:11 AM PST
 
Tuesday, May 6, 2008
SAN DIEGO--- Trisha Dowling Joins Biomatrica as Vice President, Sales and Marketing Posted 8:27 AM PST
 
Monday, May 5, 2008
Applied Biosystems & Bio-Rad Gain Gene Expression Profiling Market Share Posted 6:02 AM PST
 
Wednesday, April 30, 2008
Sequenom Announces Distribution Agreement with Invitrogen for South and Central America; Sells First MassARRAY System in Brazil Posted 4:50 PM PST
 
Invitrogen Announces Two-for-One Stock Split Posted 4:50 PM PST
 
Friday, April 25, 2008
Invitrogen to Present at Upcoming Investor Conferences Posted 6:24 AM PST
 
Wednesday, April 16, 2008
Ebioscience Corporation announced today That James Glynn Has Joined the Board Posted 8:08 AM PST
 
Wednesday, April 9, 2008
Invitrogen Teams with MitoSciences to Improve Mitochondrial Disease Research Posted 8:04 AM PST
 
Tuesday, April 1, 2008
Invitrogen Launches New Website Posted 6:36 AM PST
 
Monday, March 24, 2008
Invitrogen Offers New Animal Origin Free Foam Reduction Agent Posted 8:00 AM PST
 
Friday, March 7, 2008
Invitrogen to Present at Lehman Brothers Eleventh Annual Global Healthcare Conference Posted 7:28 AM PST
 
Friday, February 29, 2008
PORTLAND, OR--- Oregon Bioscience Association Names New Board Officers and Directors Posted 8:05 AM PST
 
Wednesday, February 27, 2008
Invitrogen Teams with Genisphere to Advance Epigenetic Research Posted 7:41 AM PST
 
Monday, February 25, 2008
Invitrogen and Chroma Therapeutics Extend Kinase Screening Partnership Posted 7:03 AM PST
 
Thursday, February 21, 2008
Invitrogen Launches Philanthropic Foundation Posted 8:11 AM PST
 
Friday, February 15, 2008
Invitrogen Announces Minority Investment in Q Therapeutics Posted 8:34 AM PST
 
Tuesday, February 12, 2008
Invitrogen Renews, Expands License and Supply Agreement with Luminex Posted 7:59 AM PST
 
Tuesday, January 29, 2008
Invitrogen to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference Posted 4:16 PM PST
 
Thursday, January 17, 2008
Invitrogen Enters Non-Coding RNA Licensing Agreement with IMBcom Posted 7:27 AM PST
 
Thursday, January 10, 2008
CARLSBAD--- Invitrogen Announces Acquisition of CellzDirect Posted 6:29 AM PST
 
Friday, December 21, 2007
Invitrogen to Present at 26th Annual JP Morgan Healthcare Conference JPMorgan 26th Annual Healthcare Conference Posted 7:01 AM PST
 
Monday, December 10, 2007
Invitrogen Exclusively Licenses Novel Click Chemistry-Based Cell Proliferation Assays from Harvard University Posted 6:32 AM PST
 
Monday, November 19, 2007
SAN DIEGO--- Jorgine Ellerbrock Joins Gen-Probe as Senior Vice President, Operations Posted 3:01 PM PST
 
Wednesday, November 14, 2007
Invitrogen and CytRx Subsidiary Rxi Pharmaceuticals Collaborate to Enhance RNAi Technologies for Therapeutic Applications Posted 7:49 AM PST
 
Wednesday, November 7, 2007
Invitrogen and Biosynth Partner to Launch Rapid Detection Products for MRSA Contamination in Hospitals Posted 7:42 AM PST
 
Thursday, October 18, 2007
Invitrogen Now Co-Exclusive Worldwide Distributor of Blue Heron Biotechnology Custom Gene Synthesis Services Posted 5:21 AM PST
 
Tuesday, October 16, 2007
Publication In PNAS Utilizes Invitrogen's ProtoArray Technology to Discover Novel Candidate Ovarian Cancer Biomarkers Posted 2:06 PM PST
 
Thursday, October 11, 2007
Invitrogen and HUPO Announce New Standard for Mass Spectrometry Posted 5:47 PM PST
 
Tuesday, October 9, 2007
Invitrogen Introduces Multiplex Kit for Stem Cells Posted 3:45 AM PST
 
Tuesday, October 2, 2007
Invitrogen and Natural Selection Team to Bring New MicroRNA Sequences to Researchers Posted 7:54 AM PST
 
Monday, October 1, 2007
SAN DIEGO--- CONNECT Announces Finalists for 20th Annual Most Innovative new Product Awards Posted 10:37 PM PST
 
Thursday, September 13, 2007
Invitrogen to Present at the UBS 2007 Global Life Science Conference Posted 8:26 AM PST
 
Thursday, August 30, 2007
Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells Posted 3:38 PM PST
 
Thursday, August 23, 2007
SAN DIEGO--- Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc. Posted 5:30 PM PST
 
Wednesday, August 15, 2007
Invitrogen’s Qubit Platform Wins 2007 R&D 100 Award Posted 7:53 AM PST
 
Tuesday, August 14, 2007
Invitrogen Launches Breakthrough Media for Human Embryonic Stem Cells Posted 6:02 AM PST
 
Thursday, August 9, 2007
Invitrogen Introduces Disposable Stem Cell Passaging Tool Posted 2:57 PM PST
 
Tuesday, July 17, 2007
Invitrogen and Biocon Announce Exclusive Agreement to Supply New Source of Insulin to Global Cell Culture Market Posted 5:31 PM PST
 
Wednesday, July 11, 2007
TalentFuse Expands Globally Through Acquisition; Announces New IT Development and On Shoring Capabilities Posted 8:14 AM PST
 
Tuesday, July 10, 2007
Digitaria and Sitecore Announce Strategic Partnership Posted 7:37 AM PST
 
SAN DIEGO--- Invitrogen Develops Prototype Hand-Held Biothreat Detectors under $3.9M Contract from Defense Threat Reduction Agency Posted 2:59 PM PST
 
Friday, June 29, 2007
Invitrogen Sets Second Quarter Earnings Release Date for Wednesday, August 1, 2007 Posted 7:09 AM PST
 
Monday, June 25, 2007
Invitrogen and Greiner Bio-One Team to Increase HPV Test Reliability Posted 7:47 AM PST
 
Friday, June 15, 2007
Invitrogen Launches New Engineered Stem Cell Line Posted 6:06 AM PST
 
Tuesday, May 8, 2007
Invitrogen Partners with Cytori to Offer Adipose Stem Cell Research Products Posted 8:37 AM PST
 
Tuesday, May 1, 2007
Invitrogen Announces First Quarter 2007 Results Posted 3:53 PM PST
 
SAN DIEGO--- Biomatrica Adds Expertise, Space Posted 8:37 AM PST
 
Monday, April 23, 2007
Invitrogen Establishes Technology Networks Posted 3:15 PM PST
 
Tuesday, April 17, 2007
Invitrogen Garners Six Life Science Industry Awards Posted 8:30 AM PST
 
Thursday, April 12, 2007
Invitrogen Completes Divestiture of BioReliance Posted 4:26 PM PST
 
Thursday, April 5, 2007
Invitrogen Sets First Quarter Earnings Release Date for Tuesday, May 1, 2007 Posted 6:00 PM PST
 
Wednesday, April 4, 2007
SAN DIEGO--- BIOCOM Announces New Board Members Posted 8:18 AM PST
 
Thursday, March 29, 2007
Invitrogen and Emiliem Sign Major Kinase Screening Agreement Posted 6:47 AM PST
 
Thursday, March 15, 2007
Invitrogen and ScienceXperts Launch Software to Demystify Multicolor Flow Cytometry Posted 3:08 PM PST
 
Wednesday, March 7, 2007
Invitrogen Dominates Cell Culture Market - Revealed in New Life Science Dashboard from Percepta Associates Posted 8:38 AM PST
 
Inovio's New Website – GeneSwitch.com – Supports Novel Gene Expression Technology Posted 9:26 AM PST
 
Tuesday, March 6, 2007
Stratagene Reports Fourth Quarter Revenue Growth Posted 4:05 PM PST
 
Friday, March 2, 2007
CARLSBAD--- Per Peterson, M.D., Ph.D., Joins Board of Directors of Invitrogen Corporation Posted 7:50 AM PST
 
Friday, February 16, 2007
Percepta Launches Life Science Dashboard Market Research Reports for Purification, Amplification & Transfection Posted 7:42 AM PST
 
Tuesday, February 13, 2007
NEW YORK--- Avista Capital Partners Agrees to Acquire BioReliance Corporation - a Business Unit of Invitrogen for Approximately $210 Million Posted 3:56 PM PST
 
Friday, February 9, 2007
Mentus Life Science Receives Three Gold Level Honors at 2006 Health Care Communicators Finest Awards Posted 3:08 PM PST
 
Tuesday, January 30, 2007
Gulf Coast Consortium Members to Use Invitrogen’s Stealth siRNA Libraries in Screening Centers Posted 7:48 AM PST
 
Monday, January 22, 2007
Invitrogen Partners with SciQuest to Provide Complete E-Procurement Solution to Customers Posted 8:03 AM PST
 
Tuesday, January 16, 2007
Invitrogen to Partner with Wave Biotech, LLC to Supply Media-Filled Disposable Bioreactor Bags Posted 7:43 AM PST
 
Wednesday, January 3, 2007
SAN DIEGO--- Quidel Names John M. Radak Chief Financial Officer Posted 9:06 AM PST
 
Wednesday, December 20, 2006
Invitrogen Introduces New Patent-Protected E-Gel Product Posted 4:03 PM PST
 
Tuesday, December 12, 2006
Invitrogen and Blue Heron Biotechnology Enter into Strategic Development and Distribution Relationship Posted 8:00 AM PST
 
Thursday, November 9, 2006
IYIA Technologies, SeQual and Reva Medical Win Awards at BIOCOM's DeviceFest Posted 4:00 PM PST
 
Wednesday, November 8, 2006
Inovio Reports Third Quarter 2006 Financial Results Posted 3:13 PM PST
 
Monday, November 6, 2006
CARLSBAD, CA--- Invitrogen Promotes European General Manager to Senior Vice President of Sales for Europe and the Americas Posted 2:19 PM PST
 
Thursday, October 26, 2006
Invitrogen Announces Third Quarter 2006 Results Posted 4:34 PM PST
 
Wednesday, October 18, 2006
Invitrogen Launches New Spin Column Format for ChargeSwitch Nucleic Acid Purification Technology Posted 7:35 AM PST
 
Tuesday, October 17, 2006
Inovio Biomedical Acquires Rights to DNA Vaccine Licenses and Intellectual Property from Valentis BIOWIRE2K Posted 6:59 AM PST
 
Wednesday, September 27, 2006
SAN DIEGO--- CONNECT Announces 2006 Most Innovative New Product (MIP) Awards Finalists Posted 3:42 PM PST
 
Tuesday, September 26, 2006
Invitrogen Adds Instrumentation Capability to Reagent Strength with Launch of Two New Devices Posted 5:09 AM PST
 
Friday, September 15, 2006
Kintera Tops Deloitte's San Diego Technology Fast 50 Ranking of Fastest-Growing Companies, With 14,159 Percent Revenue Growth Over Five Years Posted 3:58 PM PST
 
Friday, September 1, 2006
Invitrogen Corporation Expands Cellular Assay Capabilities, To Acquire Sentigen Holding Corp.; Proprietary Tango(TM) and Cell Division Arrest Technologies Complement Invitrogen's Broad Assay Technology Platform Posted 6:18 AM PST
 
Wednesday, August 23, 2006
SAN DIEGO--- Sequenom Names Michael Monko Senior Vice President of Sales and Marketing Posted 3:00 PM PST
 
Thursday, August 3, 2006
Invitrogen Announces Second Quarter 2006 Results; $500 Million Share Repurchase Authorization Posted 4:08 PM PST
 
Wednesday, July 26, 2006
HAWTHORNE--- OSI Systems Appoints New Executive Vice President and Chief Financial Officer Posted 9:44 AM PST
 
Monday, July 24, 2006
Digitaria First to Announce WebSideStory HBX Certification Posted 5:48 PM PST
 
Tuesday, July 11, 2006
Invitrogen and the Human Proteome Organisation Enter Protein Research Scientific Partnership; Groups Will Further HUPO Scientific Initiatives, Enable Standardization of Research Processes Posted 3:27 PM PST
 
Thursday, June 29, 2006
Invitrogen Licenses Geron Intellectual Property for Development of Research Tools Posted 6:34 AM PST
 
Tuesday, June 27, 2006
Nvitrogen and Cellartis Collaborate to Create hESC Multi-Lineage Reporter Lines Posted 2:13 PM PST
 
Wednesday, June 21, 2006
Affymetrix and Invitrogen Enter Into Licensing Agreement Posted 6:45 AM PST
 
Monday, June 19, 2006
STEM CELLS(R), the Journal, and Invitrogen Join to Create STEM CELLS(R) Young Investigator Award; First Awardee to Be Named at International Society for Stem Cell Research Meeting Posted 6:21 AM PST
 
Tuesday, June 13, 2006
Invitrogen and Solexa Collaborate to Supply Reagents for Next Generation Sequencing Technology; Invitrogen Reagents among Those to Be Used in Kits for Solexa Genome Analysis System Posted 6:49 AM PST
 
Tuesday, June 6, 2006
SAN DIEGO--- SoluLinK Appoints David McCarty to Its Board of Directors Posted 12:46 PM PST
 
Wednesday, May 24, 2006
CARLSBAD--- Flow Cytometry Pioneers Len and Lee Herzenberg to Join Invitrogen Flow Cytometry Scientific Advisory Board; Stanford Professor Leonard A. Herzenberg Ph.D. to Serve as Chairman Posted 2:56 PM PST
 
Tuesday, May 16, 2006
Invitrogen Announces Broad Kinase Screening Agreement with Locus Pharmaceuticals; Screening Program Will Utilize Invitrogen's SelectScreen(TM) Platform Posted 6:53 AM PST
 
Thursday, May 4, 2006
BIOCOM Announces CALBIO 2006 Posted 7:08 AM PST
 
Thursday, April 27, 2006
Invitrogen Announces First Quarter 2006 Results Posted 4:19 PM PST
 
Monday, April 17, 2006
Invitrogen Announces Preliminary First Quarter Results Posted 7:59 AM PST
 
Tuesday, April 11, 2006
Invitrogen and Signalomics Collaborate to Develop Nanotechnology-Based Approaches to Cancer Diagnostics Posted 7:20 AM PST
 
Monday, April 10, 2006
CARLSBAD--- Invitrogen Corporation Taps Renowned Stem Cell Expert Mahendra Rao, MD, Ph.D. to Lead New Research Area; Company Transforms Group of Highly-Utilized Products into Stem Cell Platform Posted 7:48 AM PST
 
Monday, March 6, 2006
Invitrogen and NIH Chemical Genomics Center Enter into Chemical Genetics Collaboration Posted 3:43 PM PST
 
Wednesday, March 1, 2006
DelSite Biotechnologies Announces Agreement with Invitrogen Corporation for Process Development of Avian H5 Influenza Nasal Vaccine Posted 8:20 AM PST
 
Tuesday, February 28, 2006
Invitrogen Announces Fourth Quarter and Full Year 2005 Results; Record Sales and Earnings Achieved Posted 5:25 PM PST
 
CARLSBAD--- James R. Glynn Retires from Invitrogen Board of Directors; Former Company Leader Departs Board after Seven Years of Service Posted 5:23 PM PST
 
Wednesday, February 22, 2006
ReliaGene Technologies Introduces Y-Screen(TM) with Invitrogen's ChargeSwitch(R) Technology for Unprecedented Specificity in Forensic Analysis of Male DNA Posted 7:46 AM PST
 
Tuesday, January 10, 2006
Invitrogen Awarded $970K Contract by U.S. Department of Defense for Production and Validation of Array-Based Biothreat Detection Platform Posted 9:09 AM PST
 
Thursday, December 15, 2005
CARLSBAD--- Xcyte Therapies and Invitrogen Announce Signing of Asset Purchase Agreement; Invitrogen to Acquire Xcyte's T Cell Expansion Technology Posted 7:14 AM PST
 
Invitrogen Enters into Worldwide Co-Marketing Agreement with genOway Focused on RNAi Services; Deal Positions Companies to Address in vivo Target Validation Market Posted 4:04 PM PST
 
Thursday, December 8, 2005
LA JOLLA--- Invitrogen President Elected to California Healthcare Institute Board Posted 3:44 PM PST
 
Tuesday, December 6, 2005
Publication in ``Nature'' Uses Invitrogen's ProtoArray Technology to Map Biological Pathways in Yeast Posted 8:59 AM PST
 
Monday, December 5, 2005
Invitrogen Announces Realignment to Move Closer to Customers; John 'Kip' Miller Signs on to Lead One of Several New Focus Areas Posted 5:54 PM PST
 
Monday, November 14, 2005
Ncode(TM) miRNA Microarray Offers Complete, Integrated Solution for miRNA Profiling Posted 8:29 AM PST
 
Wednesday, November 9, 2005
Invitrogen Introduces Stealth(TM) RNAi Human Kinase Collection; First Chemically Modified RNAi Collection to Human Protein Kinases for High-Throughput Functional Screening Posted 9:58 AM PST
 
Tuesday, November 1, 2005
Invitrogen, Procter & Gamble Extend Research Agreement; Successful RNAi Research Service Agreement Continues with Two Year Extension Posted 5:37 PM PST
 
Monday, October 31, 2005
Invitrogen and the National Center for Drug Screening (Shanghai) Announce Collaborative Research Agreement Posted 7:10 AM PST
 
Friday, October 28, 2005
ARLINGTON--- Opportunities Abound in Neuroscience for Life Science Suppliers Posted 9:07 AM PST
 
Thursday, October 27, 2005
Invitrogen Announces Third Quarter 2005 Results Posted 5:14 PM PST
 
Friday, October 14, 2005
Invitrogen Sets Third Quarter Earnings Release Date for Thursday, October 27, 2005; Conference Call and Slide Presentation will be Webcast Posted 6:14 PM PST
 
Thursday, October 6, 2005
CARLSBAD--- Invitrogen Acquires Quantum Dot and BioPixels(R), Adding Nanotechnology Portfolio to Its Molecular Probes Franchise; Company Also Closes Acquisition of Biosource International, Inc. Posted 9:28 AM PST
 
Wednesday, September 28, 2005
Invitrogen Launches Vector NTI(R) Advance(TM) 10; Release Includes Vector NTI(R) Open Access Policy and Vector NTI(R) User Community to Drive Life Science Standardization Posted 10:11 AM PST
 
Tuesday, September 27, 2005
Invitrogen to Present at UBS Global Life Sciences Conference Posted 9:53 AM PST
 
Wednesday, September 21, 2005
PerkinElmer and Invitrogen Enter into Strategic Agreement to Streamline Drug Development Posted 4:41 PM PST
 
Tuesday, September 13, 2005
Invitrogen Corporation and Fred Hutchinson Cancer Research Center Team on Cancer Screening; Collaboration Will Use Proteomics Technologies to Focus on Early Cancer Diagnostics Posted 6:16 PM PST
 
Wednesday, August 31, 2005
CARLSBAD--- Invitrogen Promotes David Onions, Ph.D. to Chief Medical Officer; Scientific Leader to Help Company Transition toward Patient-Centric Support Technologies Posted 9:34 AM PST
 
Tuesday, August 30, 2005
Invitrogen Corporation Expands Protein Electrophoresis Portfolio with Introduction of Wide Format Gels Posted 9:25 AM PST
 
Monday, August 29, 2005
Invitrogen Signs Agreement with Nonlinear Dynamics to Distribute Advanced Analysis Software Solutions Posted 9:51 AM PST
 
Friday, August 12, 2005
CARLSBAD--- Ortho Organizers, Inc. Announces Change in Ownership Posted 5:08 PM PST
 
Thursday, July 28, 2005
Invitrogen Announces Second Quarter 2005 Results; Strong Revenue Drives 21% Pro Forma Earnings Growth Posted 6:00 PM PST
 
Tuesday, July 26, 2005
CARLSBAD--- Invitrogen Signs Definitive Agreement to Acquire BioSource International; Deal Strengthens Proteomics Franchise and Positions the Company to Enter New Markets Posted 9:24 AM PST
 
Monday, July 18, 2005
Invitrogen Opens Australian cGMP Manufacturing Facility; New Operation Increases Worldwide Capacity in Serum Development Posted 9:14 PM PST
 
Friday, July 8, 2005
Invitrogen Sets Second Quarter Earnings Release Date for Thursday, July 28, 2005; Conference Call and Slide Presentation Will Be Webcast Posted 9:56 PM PST
 
Friday, June 24, 2005
CARLSBAD--- Peter Leddy, Ph.D., Joins Invitrogen Corporation as Senior Vice President of Human Resources Posted 9:16 AM PST
 
Wednesday, June 22, 2005
CARLSBAD--- Invitrogen Corporation Completes Sale of $350 Million of 3.25% Senior Convertible Notes Due 2025 Posted 5:47 PM PST
 
Monday, June 20, 2005
Invitrogen Launches i-Path -- A Unique Systems Biology Platform at BIO 2005; 225 Original Maps Identifying and Visualizing Biologic Pathways, Available Free to Researchers Posted 9:11 AM PST
 
Monday, June 13, 2005
Invitrogen Corporation Announces Offering of Convertible Senior Notes Due 2025 Posted 4:14 PM PST
 
Monday, May 16, 2005
CARLSBAD--- Invitrogen to Acquire Immunological Reagent Provider Caltag Laboratories; Deal Adds Expertise in Assays for Flow Cytometry to Strengthen Invitrogen's Growing Proteomics Portfolio Posted 9:34 AM PST
 
Tuesday, May 3, 2005
CARLSBAD--- Invitrogen Promotes Mark Gardner to Chief Marketing Officer; Process Excellence and Marketing Expert to Expand Reach to Customers Through Broad Range of Channels Posted 8:26 PM PST
 
Thursday, April 28, 2005
Invitrogen Announces First Quarter 2005 Results; Record Sales and Pro Forma Earnings Achieved Posted 6:04 PM PST
 
Wednesday, April 13, 2005
SAN DIEGO--- Stressgen Announces Sale of Bioreagents Business for Approximately $8.0 million Posted 5:12 PM PST
 
Thursday, April 7, 2005
Invitrogen Corp., Agilent Technologies to Market PathAlert Infectious Agent Detection System, Recently Proven in Government/Military Testing; System Enables Fast, Accurate Detection of Biopathogens Posted 8:22 AM PST
 
Invitrogen Sets First Quarter Earnings Release Date for Thursday, April 28, 2005; Conference Call and Slide Presentation Will Be Webcast Posted 5:54 PM PST
 
Wednesday, April 6, 2005
Invitrogen Signs Broad Kinase Screening Agreement with Plexxikon Posted 6:10 PM PST
 
Friday, April 1, 2005
CARLSBAD--- Invitrogen Completes Acquisition of Dynal Posted 10:15 AM PST
 
Thursday, March 24, 2005
SAN DIEGO--- BIOCOM Announces New Board Officers and Board Members Posted 5:49 PM PST
 
Tuesday, March 8, 2005
Invitrogen to Present at JPMorgan Small Cap Conference Posted 5:00 PM PST
 
Tuesday, March 1, 2005
Renowned Biotech Pioneer Dr. Leroy Hood to Lecture at San Diego State University Posted 5:28 PM PST
 
Tuesday, February 22, 2005
Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2004; Revenue Increases by 80% over Prior Year Posted 6:43 PM PST
 
Thursday, February 17, 2005
Invitrogen Announces Fourth Quarter and Full Year 2004 Results; Record Sales and Pro Forma Earnings Achieved Posted 7:28 PM PST
 
Monday, February 14, 2005
CARLSBAD--- W. Ann Reynolds, Ph.D. Joins Invitrogen Corporation's Board of Directors Posted 7:44 PM PST
 
Monday, January 10, 2005
CARLSBAD--- Invitrogen Signs Definitive Agreement to Acquire Zymed Laboratories, Inc. for $60 Million in Cash Posted 9:40 AM PST
 
Thursday, January 6, 2005
Diversa Corporation to Present at the JPMorgan 23rd Annual Healthcare Conference With Simultaneous Webcast Posted 8:45 AM PST
 
Tuesday, January 4, 2005
Invitrogen Efficiently Handles Complex Scientific Inquiries Across All Customer Channels With RightNow Posted 9:18 AM PST
 
Monday, December 20, 2004
Invitrogen and Illumina Announce Strategic Alliance Combining DNA Synthesis, Distribution and Marketing Strengths for Global Life Sciences Customers Posted 6:05 PM PST
 
Wednesday, September 8, 2004
Diversa Awarded NIH Grant to Develop New Antibodies Targeting SARS Posted 9:00 AM PST
 
Thursday, August 12, 2004
Invitrogen Corporation and Exelixis Enter into Collaborative Research Agreement Posted 9:09 AM PST
 
Friday, August 6, 2004
CARLSBAD--- Ronald A. Matricaria Joins Invitrogen Corp.'s Board of Directors Posted 6:37 PM PST
 
Tuesday, August 3, 2004
LA JOLLA--- The Burnham Institute Appoints Vice President of Business Development Posted 6:04 PM PST
 
Tuesday, July 27, 2004
Syngenta and Diversa Strengthen Their Collaboration Posted 8:35 AM PST
 
Monday, July 26, 2004
ARLINGTON, VA--- Study Finds Ample Opportunities for Life Science Suppliers in the Biodefense Market Posted 9:39 AM PST
 
Diversa Reports Financial Results for the Quarter and Six Months Ended June 30, 2004 Posted 5:50 PM PST
 
Wednesday, July 21, 2004
Invitrogen Announces Second Quarter 2004 Results; Record Sales and Pro Forma Earnings Achieved Posted 9:03 AM PST
 
Monday, July 19, 2004
Diversa Signs Agreement With GlaxoSmithKline to Advance Development of a Novel Anti-Infective Compound Posted 9:55 AM PST
 
Thursday, July 15, 2004
Diversa Launches Luminase(TM) Enzyme for Improved Pulp Bleaching Posted 9:24 AM PST
 
Tuesday, July 13, 2004
CARLSBAD--- Invitrogen Creates Biological Defense Systems Inc. Subsidiary; Company Appoints Industry Veteran To Top Biodefense Research Position Posted 9:17 AM PST
 
Monday, July 12, 2004
Diversa Mid-Year Conference Call Scheduled for July 27, 2004 Posted 6:43 PM PST
 
Monday, June 28, 2004
Diversa Corporation Ranked Among Top Places to Work in the Life Science Industry by The Scientist Magazine Posted 8:04 AM PST
 
Thursday, June 17, 2004
Diversa Launches Cottonase(TM) Textile Processing Enzyme in the U.S. Posted 9:20 AM PST
 
Tuesday, June 15, 2004
CARLSBAD--- Dr. Craig Mello Takes Advisory Role with Invitrogen; Inventor of RNA Interference Method to Assist in Fast Growing Segment Of Company Posted 5:27 PM PST
 
Monday, June 14, 2004
Diversa Announces Updated Financial Guidance for the Second Quarter Posted 8:52 AM PST
 
Diversa Corporation Achieves 2004 Milestones Under Syngenta Agreements Posted 8:53 AM PST
 
Tuesday, June 8, 2004
Invitrogen Releases First Microarray with Yeast Proteome; Breakthrough Technology Will Follow with Human Protein Array Subsets in Late 2004 Posted 8:52 AM PST
 
Invitrogen Releases First Microarray With Yeast Proteome Posted 8:32 PM PST
 
Tuesday, June 1, 2004
GeneGo Enters Licensing Agreement With Invitrogen Corporation Posted 8:39 AM PST
 
Tuesday, May 11, 2004
Invitrogen Selects Agile PLM Solutions to Provide Best Practice Program Management, Change Control and Collaboration Capabilities Posted 8:51 AM PST
 
Monday, May 10, 2004
SAN DIEGO--- WebSideStory Names CFO and Two New Directors Posted 9:14 AM PST
 
Thursday, April 29, 2004
Diversa Corporation to Present at the Deutsche Bank Securities 29th Annual Health Care Conference With Simultaneous Webcast Posted 8:46 AM PST
 
Thursday, April 22, 2004
Invitrogen Announces First Quarter 2004 Results; Record Sales and Pro Forma Earnings Achieved and Raises Full Year Guidance Posted 9:50 AM PST
 
Wednesday, April 21, 2004
Diversa Scientists First to Link Protein Function to Genetic Sequence Information Derived From Complex Microbial Communities Posted 9:10 AM PST
 
Diversa Reports Financial Results for the Quarter Ended March 31, 2004 Posted 5:47 PM PST
 
Tuesday, April 13, 2004
LA JOLLA--- Jay M. Short, Ph.D. Joins the Board of Directors of Senomyx, Inc. Posted 9:24 AM PST
 
Wednesday, April 7, 2004
SAN DIEGO--- Diversa CFO Departs Posted 8:31 AM PST
 
Friday, April 2, 2004
CARLSBAD--- Invitrogen Corporation Acquires Protometrix, Inc.; Breakthrough Protein Microarray Technology to Offer Benchtop Access to the Human Proteome Posted 10:28 AM PST
 
Monday, March 22, 2004
SAN DIEGO--- UCSD Athena Announces Pinnacle Awards Nominees Posted 4:44 PM PST
 
Monday, February 23, 2004
Diversa Establishes Manufacturing Agreement for Enzyme Production With Fermic Posted 9:49 AM PST
 
Thursday, February 12, 2004
Invitrogen Announces Offering of Convertible Notes Posted 9:09 AM PST
 
Wednesday, February 11, 2004
SAN DIEGO--- Diversa Appoints Cheryl A. Wenzinger to Its Board of Directors Posted 8:50 AM PST
 
Monday, February 9, 2004
Diversa Reports Financial Results for the Quarter And Year Ended December 31, 2003 Posted 3:58 PM PST
 
Friday, February 6, 2004
Invitrogen Announces Expiration of Its Cash Tender Offer for BioReliance Corporation Posted 9:12 AM PST
 
Thursday, February 5, 2004
Diversa Corporation To Announce Fourth Quarter and Full-Year Financial Results and Provide Guidance Posted 8:47 AM PST
 
Tuesday, February 3, 2004
SDSU Business School Teams with Biotechnology Powerhouses to Launch Combined Life Science Ph.D. and MBA Program Posted 9:14 AM PST
 
Monday, January 26, 2004
Invitrogen Sets 4th Quarter and Full Year 2003 Earnings Release Date for Thursday, February 12, 2004; Conference Call and Slide Presentation will be Webcast Posted 9:50 AM PST
 
Thursday, January 15, 2004
DSM and Diversa Corporation Sign Agreement to Develop Biocatalysts for Production of Pharmaceutical Intermediates Posted 8:28 PM PST
 
Wednesday, January 14, 2004
Diversa Corporation Achieves 2003 Milestones Under Syngenta Agreements Posted 8:05 AM PST